Skip to main content

Mounjaro

NDC 0002-1506 · Eli Lilly and Company

Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength2.5 mg/.5mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA

Packages

0002-1506-61 — 4 SYRINGE in 1 CARTON (0002-1506-61) / .5 mL in 1 SYRINGE

0002-1506-80 — 4 SYRINGE in 1 CARTON (0002-1506-80) / .5 mL in 1 SYRINGE (0002-1506-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0002-1152 — tirzepatide, 0002-1214 — tirzepatide, 0002-1243 — tirzepatide, 0002-1340 — tirzepatide, 0002-1423 — tirzepatide, 0002-1457 — tirzepatide, 0002-1460 — tirzepatide, 0002-1471 — tirzepatide, 0002-1484 — tirzepatide, 0002-1495 — tirzepatide, 0002-2002 — tirzepatide, 0002-2214 — tirzepatide, 0002-2340 — tirzepatide, 0002-2423 — tirzepatide, 0002-2457 — tirzepatide, 0002-2460 — tirzepatide, 0002-2471 — tirzepatide, 0002-2484 — tirzepatide, 0002-2495 — tirzepatide, 0002-2506 — tirzepatide, +33 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.